Overview
The goal of this observational study is to evaluate the feasibility and clinical utility of radiomics to diagnose peri-lesion tumour infiltration of tumours in participants with a suspect of Bone Cancer Tumor or Soft Tissue Sarcoma (STS).
The main questions it aims to answer are:
- is radiomics able to identify the ratio of participants truly diagnosed as positive to all those who had positive test results?
- is radiomics able to identify the likelihood that a participant who has a negative test result indeed does not have the disease?
Participants eligible for this study will get a MRI as part of their regular medical care. The only difference is that their data will be recorded and anonymously analyzed.
Eligibility
Inclusion Criteria:
- Age over 18
- suspect of soft tissue sarcoma with a indication for surgical treatment
- suspect of bone cancer tumor with a indication for surgical treatment
- To give informed consent
Exclusion Criteria:
- simultaneous cancer or history of cancer in the last 5 years
- acute or chronic serious conditions that could
- contraindication to conduct a Contrast-enhanced magnetic resonance imaging (MRI)
such as:
- renal failure without dialysis
- history of allergy to a paramagnetic contrast agent
- claustrophobia
- symptomatic epilepsy or history of epilepsy
- cardiac pacemaker
- infusion pump, prosthesis or any implant not compatible with MRI
- pregnancy